James Maple, sitting in for Amy, and Patrick present the audio from BloodStream’s Diversity, Equity, and Inclusivity panel during National Hemophilia Foundation’s Bleeding Disorders Conference as well as the latest from the Let’s Talk mental health segment. Plus, news from ICER on gene therapy!
Show Notes:
Subscribe:
Article:
Hemophilia gene therapies from BioMarin, CSL pick up an early ICER endorsement
Presenting Sponsor:
- Takeda, visit bleedingdisorders.com to learn more.
Episode and Segment Sponsors:
- CSL Behring, visit HemEvolution.com to learn more about gene therapy, or ProtraitsofProgress.com for a virtual photo exhibition chronicling hemophilia’s history
- Sanofi, visit ShareYourWhy.com to meet the CoRe team and hear stories from the hemophilia community.
- Pfizer, if you have sickle cell disease, how often do painful crises have you visiting the doctor? Learn more at ClinicalTrialSCD.com
Connect with BloodStream Media:
BloodStream welcomes back frequents collaborators, Cazandra Campos-Macdonald & Laurence Woollard. Caz shares an emotional update on her chronic pain and mental health, while Laurence tells us about the impressive recent episode of Global Hemophilia Report featuring women with bleeding disorders.
Show Notes:
Presenting Sponsor: Takeda. Visit bleedingdisorders.com to learn more.
Subscribe to BloodStream Podcast
Listen to the latest from BloodStream’s FLOW podcast
Brought to you in party by Genentech #Genentech #hemophiliacommunity #BleedingDisorders #Hemophilia #HemophiliaA #Healthcare
Brought to you in part by CSL Behring. To learn more, check out www.HemEvolution.com
If you have sickle cell disease, how often do painful crises have you visiting the doctor? Pfizer is now enrolling a research study of an investigational medicine that may help to prevent pain crises caused by sickle cell disease. If you have seen a healthcare provider for 2 to 10 sickle cell crises in the past year, you may be able to participate. To speak with the study team, visit ClinicalTrialSCD.com. With your help, we can pursue new treatment options for sickle cell disease. Learn more at ClinicalTrialSCD.com or click the link in the show notes.
Connect with BloodStream Media: